Publication: Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas
Issued Date
2020-01-01
Resource Type
ISSN
22124403
Other identifier(s)
2-s2.0-85087803325
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. (2020)
Suggested Citation
Puangwan Lapthanasupkul, Tuntikorn Laosuk, Preecha Ruangvejvorachai, Anchisa Aittiwarapoj, Nakarin Kitkumthorn Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. (2020). doi:10.1016/j.oooo.2020.06.002 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/57858
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas
Other Contributor(s)
Abstract
© 2020 Elsevier Inc. Objective: BRAF V600E mutation has recently been reported in a high proportion of ameloblastomas. This study was conducted to investigate the frequency of this mutation in ameloblastoma and unicystic ameloblastoma. The correlation between clinicopathologic data and BRAF V600E mutation was also analyzed. Study Design: A total of 51 archival samples of ameloblastomas and 22 cases of unicystic ameloblastomas were examined for BRAF V600E mutation by using anti-BRAF V600E (clone VE1) immunohistochemistry. Results: Positivity for anti-BRAF V600E antibody was detected in 72.5% (37 of 51) of ameloblastomas, but the mutation showed no significant correlation with the clinicopathologic parameters. With regard to unicystic ameloblastoma, 95.5% (21) of the 22 cases exhibited positive immunostaining for BRAF V600E, whereas only 1 case showed the mural subtype of wild-type BRAF. Conclusions: A high frequency of BRAF V600E mutation was detected in a group of Thai patients with ameloblastomas, suggesting the future use of BRAF-targeted therapy in patients with BRAF-mutated ameloblastoma. However, no significant association between BRAF V600E mutation and the clinicopathologic characteristics of ameloblastomas was found in our study.